Literature DB >> 26101072

Regional β-amyloid burden does not correlate with cognitive or language deficits in Alzheimer's disease presenting as aphasia.

Y Jung1, J L Whitwell2, J R Duffy1, E A Strand1, M M Machulda3, M L Senjem4, C R Jack2, V J Lowe5, K A Josephs1.   

Abstract

BACKGROUND AND
PURPOSE: A subset of patients with Alzheimer's disease (AD) present with early and prominent language impairment (aphasic AD). Our previous study demonstrated an association between global β-amyloid burden measured on [(11)C] Pittsburgh compound B (PiB) positron emission tomography and general cognitive impairment, but not with aphasia, in such subjects. As a follow-up, whether there is any association between regional β-amyloid burden, atrophy on magnetic resonance imaging (MRI) and global cognitive impairment, aphasia or other cognitive and functional impairment in aphasic AD is assessed.
METHODS: Forty-four aphasic AD subjects who underwent PiB scanning and volumetric MRI and were determined to be positive for β-amyloid deposition were analyzed. All had completed detailed neurological, neuropsychological and language batteries. Spearman's rank-order correlation was utilized to assess for associations.
RESULTS: Greater visuospatial impairment was associated with increased β-amyloid burden in the primary visual cortex (P = 0.001). Although there were many trends for associations between neurocognitive and language deficits and regional β-amyloid burden, there were no strong associations that survived correction for multiple comparisons. However, neurocognitive and language impairment in these subjects strongly correlated with the degree of left lateral temporal and inferior parietal atrophy (P < 0.004).
CONCLUSIONS: The findings from this study suggest a close relation between the severity of regional atrophy and cognitive and language impairment, but argue against a strong association between regional β-amyloid burden and such deficits in aphasic AD subjects. Hence, other pathological factors may be driving the previously identified association between global β-amyloid deposition and general cognitive impairment in aphasic AD.
© 2015 EAN.

Entities:  

Keywords:  PET; PiB; aphasia; beta-amyloid; dementia

Mesh:

Substances:

Year:  2015        PMID: 26101072      PMCID: PMC4689664          DOI: 10.1111/ene.12761

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  27 in total

1.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

2.  High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters.

Authors:  A Forsberg; O Almkvist; H Engler; A Wall; B Långström; A Nordberg
Journal:  Curr Alzheimer Res       Date:  2010-02       Impact factor: 3.498

3.  Amyloid burden correlates with cognitive decline in Alzheimer's disease presenting with aphasia.

Authors:  Y Jung; J L Whitwell; J R Duffy; E A Strand; M M Machulda; M L Senjem; V Lowe; C R Jack; K A Josephs
Journal:  Eur J Neurol       Date:  2013-12-16       Impact factor: 6.089

4.  Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study.

Authors:  Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Rong Xia; Jay Mandrekar; Mary M Machulda; Matthew L Senjem; Val J Lowe; Clifford R Jack; Keith A Josephs
Journal:  Brain Lang       Date:  2013-03-28       Impact factor: 2.381

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  An empirically derived short form of the Boston naming test.

Authors:  A E Lansing; R J Ivnik; C M Cullum; C Randolph
Journal:  Arch Clin Neuropsychol       Date:  1999-08       Impact factor: 2.813

7.  Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

Authors:  Renaud La Joie; Audrey Perrotin; Louisa Barré; Caroline Hommet; Florence Mézenge; Méziane Ibazizene; Vincent Camus; Ahmed Abbas; Brigitte Landeau; Denis Guilloteau; Vincent de La Sayette; Francis Eustache; Béatrice Desgranges; Gaël Chételat
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

8.  Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.

Authors:  K A Josephs; J L Whitwell; J R Duffy; W A Vanvoorst; E A Strand; W T Hu; B F Boeve; N R Graff-Radford; J E Parisi; D S Knopman; D W Dickson; C R Jack; R C Petersen
Journal:  Neurology       Date:  2008-01-01       Impact factor: 9.910

9.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration.

Authors:  Jonathan D Rohrer; Matthew J Clarkson; Raivo Kittus; Martin N Rossor; Sebastien Ourselin; Jason D Warren; Nick C Fox
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

View more
  6 in total

Review 1.  Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.

Authors:  Alberto Villarejo-Galende; Sara Llamas-Velasco; Adolfo Gómez-Grande; Verónica Puertas-Martín; Israel Contador; Pilar Sarandeses; Marta González-Sánchez; Rocío Trincado; Patrick Pilkington; Sebastián Ruiz-Solis; David A Pérez-Martínez; Alejandro Herrero-San Martín
Journal:  J Neurol       Date:  2016-11-04       Impact factor: 4.849

2.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

3.  PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.

Authors:  Ivan Koychev; Roger N Gunn; Azadeh Firouzian; Jennifer Lawson; Giovanna Zamboni; Basil Ridha; Barbara J Sahakian; James B Rowe; Alan Thomas; Lynn Rochester; Dominic Ffytche; Robert Howard; Henrik Zetterberg; Clare MacKay; Simon Lovestone
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Amyloid, APP, and Electrical Activity of the Brain.

Authors:  Dimitri Hefter; Susann Ludewig; Andreas Draguhn; Martin Korte
Journal:  Neuroscientist       Date:  2019-11-29       Impact factor: 7.519

5.  Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy.

Authors:  Andrew J Trease; Joseph W George; Nashanthea J Roland; Eliezer Z Lichter; Katy Emanuel; Steven Totusek; Howard S Fox; Kelly L Stauch
Journal:  Front Mol Neurosci       Date:  2022-03-10       Impact factor: 5.639

6.  Evaluation of serum galectin-3 levels at Alzheimer patients by stages: a preliminary report.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Murat Cihan
Journal:  Acta Neurol Belg       Date:  2020-08-27       Impact factor: 2.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.